Market Cap 7.43B
Revenue (ttm) 18.47M
Net Income (ttm) -589.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,191.82%
Debt to Equity Ratio -0.38
Volume 1,584,100
Avg Vol 1,815,260
Day's Range N/A - N/A
Shares Out 122.27M
Stochastic %K 49%
Beta 0.58
Analysts Strong Sell
Price Target $79.79

Company Profile

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. It a...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 624 3000
Address:
350 Oyster Point Boulevard, South San Francisco, United States
Jonita
Jonita Dec. 12 at 8:49 PM
$CYTK 💣💣💣💣
0 · Reply
biochirp
biochirp Dec. 12 at 6:31 PM
$CYTK JPM names should start going here $VKTX $ABVX $PTGX
0 · Reply
ElizabethLee1023
ElizabethLee1023 Dec. 12 at 3:09 PM
$CYTK Cytokinetics Announces Positive CHMP Opinion of MYQORZO® (Aficamten) for the Treatment of Obstructive Hypertrophic Cardiomyopathy
1 · Reply
11thestate
11thestate Dec. 12 at 3:08 PM
When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there’s some good news. $CYTK investors — you might be surprised, but you actually have a chance to recover your losses. Don’t miss it. https://11th.com/cases/cytokinetics-investor-suit
0 · Reply
JarvisFlow
JarvisFlow Dec. 12 at 10:57 AM
Needham updates rating for Cytokinetics ( $CYTK ) to Buy, target set at 72.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:51 PM
Actionable Trade Alert for $CYTK: Market Context: $CYTK closed at $59.99, with an RSI of 40.7 indicating a potential oversold condition. The stock is currently below its 30-day (MA30) and 50-day (MA50) moving averages, suggesting a bearish trend in the short term. However, the RSI indicates a possible reversal opportunity. Directional Bias: Given the current price relative to the 60D high of $69.33 and low of $47.22, there is room for upward movement. The ATR of 2.51 suggests moderate volatility, allowing for potential price swings. Trade Plan: - Suggested Entry: $60.50 (slightly above the last close to confirm upward momentum) - Stop Loss: $57.00 (to limit risk) - Take Profit Targets: 1. $64.00 (approx. 5.5% gain) 2. $67.00 (approx. 10.5% gain) 3. $70.00 (approx. 17% gain) This setup provides a solid risk-reward ratio, targeting a minimum of 17% ROI on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
merlin8121
merlin8121 Dec. 11 at 7:27 PM
$CYTK https://www.merlintrader.com/cytk-cytokinetics/
0 · Reply
CrispDry
CrispDry Dec. 10 at 3:41 PM
$CYTK terribly annoying but gonna hold until PDUFA (which lands on my birthday)
0 · Reply
Jonita
Jonita Dec. 10 at 10:43 AM
$CYTK 💣💣💣💣
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:54 AM
Actionable Trade Alert for $CYTK: Market Context: $CYTK is currently trading at $61.6, showing a bearish sentiment with RSI at 38.55, indicating potential oversold conditions. The price is below both the 30-day MA (64.19) and the 50-day MA (62.0), suggesting downward pressure. The recent high of $69.33 and low of $47.22 establishes a range that can be leveraged for potential gains. Directional Bias: Given the current RSI and the position relative to MAs, there is a potential for a reversal as it approaches the lower end of the 60-day range. Trade Plan: - Suggested Entry: $61.6 - Stop Loss: $58.0 (approx. 4.3% risk) - Take Profit Targets: 1. $64.0 (5.8% gain) 2. $67.0 (8.6% gain) 3. $72.0 (17% gain) With a well-structured risk-reward ratio, this trade offers a solid opportunity for profit. Monitor closely for market shifts. https://privateprofiteers.com
0 · Reply
Latest News on CYTK
3 Potential Mid-Cap Biotech Buyout Targets In 2026

Dec 3, 2025, 6:22 PM EST - 9 days ago

3 Potential Mid-Cap Biotech Buyout Targets In 2026

COGT IBB TVTX XBI


Cytokinetics: A Heavily Mispriced Cardiovascular Platform

Nov 19, 2025, 7:40 AM EST - 24 days ago

Cytokinetics: A Heavily Mispriced Cardiovascular Platform


Cytokinetics to Participate in November Investor Conferences

Nov 4, 2025, 4:00 PM EST - 5 weeks ago

Cytokinetics to Participate in November Investor Conferences


Cytokinetics, Inc. Investigated by the Portnoy Lawfirm

Sep 18, 2025, 4:23 PM EDT - 3 months ago

Cytokinetics, Inc. Investigated by the Portnoy Lawfirm


Jonita
Jonita Dec. 12 at 8:49 PM
$CYTK 💣💣💣💣
0 · Reply
biochirp
biochirp Dec. 12 at 6:31 PM
$CYTK JPM names should start going here $VKTX $ABVX $PTGX
0 · Reply
ElizabethLee1023
ElizabethLee1023 Dec. 12 at 3:09 PM
$CYTK Cytokinetics Announces Positive CHMP Opinion of MYQORZO® (Aficamten) for the Treatment of Obstructive Hypertrophic Cardiomyopathy
1 · Reply
11thestate
11thestate Dec. 12 at 3:08 PM
When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there’s some good news. $CYTK investors — you might be surprised, but you actually have a chance to recover your losses. Don’t miss it. https://11th.com/cases/cytokinetics-investor-suit
0 · Reply
JarvisFlow
JarvisFlow Dec. 12 at 10:57 AM
Needham updates rating for Cytokinetics ( $CYTK ) to Buy, target set at 72.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:51 PM
Actionable Trade Alert for $CYTK: Market Context: $CYTK closed at $59.99, with an RSI of 40.7 indicating a potential oversold condition. The stock is currently below its 30-day (MA30) and 50-day (MA50) moving averages, suggesting a bearish trend in the short term. However, the RSI indicates a possible reversal opportunity. Directional Bias: Given the current price relative to the 60D high of $69.33 and low of $47.22, there is room for upward movement. The ATR of 2.51 suggests moderate volatility, allowing for potential price swings. Trade Plan: - Suggested Entry: $60.50 (slightly above the last close to confirm upward momentum) - Stop Loss: $57.00 (to limit risk) - Take Profit Targets: 1. $64.00 (approx. 5.5% gain) 2. $67.00 (approx. 10.5% gain) 3. $70.00 (approx. 17% gain) This setup provides a solid risk-reward ratio, targeting a minimum of 17% ROI on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
merlin8121
merlin8121 Dec. 11 at 7:27 PM
$CYTK https://www.merlintrader.com/cytk-cytokinetics/
0 · Reply
CrispDry
CrispDry Dec. 10 at 3:41 PM
$CYTK terribly annoying but gonna hold until PDUFA (which lands on my birthday)
0 · Reply
Jonita
Jonita Dec. 10 at 10:43 AM
$CYTK 💣💣💣💣
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:54 AM
Actionable Trade Alert for $CYTK: Market Context: $CYTK is currently trading at $61.6, showing a bearish sentiment with RSI at 38.55, indicating potential oversold conditions. The price is below both the 30-day MA (64.19) and the 50-day MA (62.0), suggesting downward pressure. The recent high of $69.33 and low of $47.22 establishes a range that can be leveraged for potential gains. Directional Bias: Given the current RSI and the position relative to MAs, there is a potential for a reversal as it approaches the lower end of the 60-day range. Trade Plan: - Suggested Entry: $61.6 - Stop Loss: $58.0 (approx. 4.3% risk) - Take Profit Targets: 1. $64.0 (5.8% gain) 2. $67.0 (8.6% gain) 3. $72.0 (17% gain) With a well-structured risk-reward ratio, this trade offers a solid opportunity for profit. Monitor closely for market shifts. https://privateprofiteers.com
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 9 at 9:35 PM
Hedge Alert Live - Protect Your Portfolio Contract: $CYTK $60.00 Put · DEC 19, 2025 Exp Entry Price: $2.00 - $2.50 Exit Price Target: $4.42 Profit Margin: +121% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
CarlosLacombe
CarlosLacombe Dec. 9 at 1:46 PM
@CarlosLacombe $CYTK Cytokinetics CCO Andrew Callos exercised 1,042 options at $39.13 and sold equal shares at $65.96 via a 10b5-1 plan. Post-trade he holds 50,660 shares and 35,403 options.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:42 PM
Actionable Trade Alert for $CYTK: Market Context: $CYTK is currently trading at $64.16, showing potential for upward movement given its recent price action and technical indicators. The RSI at 42.31 suggests it is nearing oversold territory, indicating a potential reversal. Directional Bias: The price is above the 30-day moving average (MA30) of $64.15 and significantly above the 50-day moving average (MA50) of $61.85, suggesting bullish momentum. The 60-day high of $69.33 offers a strong resistance level, while the 60-day low of $47.22 provides a solid support base. Trade Plan: - Suggested Entry: $64.50 - Stop Loss: $61.50 (approximately 4.67% risk) - Take Profit Targets: 1. $67.00 (Target 1, approx. 3.9% gain) 2. $69.00 (Target 2, approx. 7.5% gain) 3. $75.00 (Target 3, approx. 16.9% gain) This plan offers a potential ROI of over 17% on the third target, making it a compelling trade setup. https://privateprofiteers.com
0 · Reply
justiceforb_85
justiceforb_85 Dec. 8 at 7:44 PM
$CYTK not quite understanding the price action going into the PDUFA with likely approval and new SoC in oHCM.
1 · Reply
BullRun4
BullRun4 Dec. 6 at 3:59 AM
$CYTK 🚨🚨take a look at Cardiff Oncology Oncology CRDF, they are expecting a very strong catalyst in Q1. 💰💰💰💰💰💰💰💰💰💰💰💰💰💰
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:42 AM
Actionable Trade Alert for $CYTK: Market Context: $CYTK closed at $66.54, showing resilience above the 30-day moving average (MA30) of $63.66 and the 50-day moving average (MA50) of $61.22. The Relative Strength Index (RSI) at 52.97 indicates neutral momentum, suggesting potential for upward movement. Directional Bias: The stock is positioned well within its 60-day range (high of $69.33 and low of $47.22), indicating bullish potential as it approaches the recent high. With the current price above both MAs, we maintain a bullish outlook. Trade Plan: - Suggested Entry: $66.54 - Stop Loss: $63.00 (below MA30) - Take Profit Targets: 1. $68.00 (2.2% gain) 2. $70.00 (5.5% gain) 3. $77.00 (15.7% gain, 17% ROI) This plan allows for a strategic entry with a favorable risk-reward ratio. Monitor the stock closely for any signs of momentum shifts. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:17 PM
Actionable Trade Alert for $CYTK: Market Context: $CYTK closed at $66.54, showing resilience above the 30-day moving average (MA30) of $63.66 and the 50-day moving average (MA50) of $61.22. The Relative Strength Index (RSI) at 52.97 indicates neutral momentum, suggesting potential for upward movement. Directional Bias: The stock is positioned well within its 60-day range (high of $69.33 and low of $47.22), indicating bullish potential as it approaches the recent high. With the current price above both MAs, we maintain a bullish outlook. Trade Plan: - Suggested Entry: $66.54 - Stop Loss: $63.00 (below MA30) - Take Profit Targets: 1. $68.00 (2.2% gain) 2. $70.00 (5.5% gain) 3. $77.00 (15.7% gain, 17% ROI) This plan allows for a strategic entry with a favorable risk-reward ratio. Monitor the stock closely for any signs of momentum shifts. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 4 at 10:03 PM
$CYTK Current Stock Price: $66.54 Contracts to trade: $65 CYTK Dec 19 2025 Call Entry: $3.00 Exit: $5.64 ROI: 88% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 4 at 7:01 AM
Hedge Alert Live - Protect Your Portfolio Contract: $CYTK $60.00 Put · DEC 19, 2025 Exp Entry Price: $2.60 - $2.70 Exit Price Target: $5.98 Profit Margin: +130% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
OptionRunners
OptionRunners Dec. 3 at 4:59 PM
$CYTK Trader sold (to close) the January 16th 2026 $55 calls 7,500 times for $13.80 and bought (to open) the April 17th 2026 $75 calls 5,000 times for $10.70. The trader is rolling/adjusting the calls out and up for a $5M credit. These are up being adjusted again.
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 1 at 9:53 PM
Hedge Alert Live - Protect Your Portfolio Contract: $CYTK $65.00 Put · DEC 19, 2025 Exp Entry Price: $3.30 - $3.60 Exit Price Target: $6.60 Profit Margin: +100% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Nov. 26 at 12:41 PM
$CYTK Seriously, with the December FDA approval, what would be a reasonable BO price? $100? $200? Asking for a friend. THX
1 · Reply